STAT News

Tier A health

In-depth health news and investigative reporting

Tier A 76 score Mixed credibility 1,081 articles

STAT News is a reputable health-focused news outlet that provides in-depth analysis and reporting on medical research, healthcare policies, and emerging health trends. Its coverage aims to inform professionals and the general public about critical developments in the health sector through a rigorous

Showing 40 of 1,081 articles

health STAT News · 11d ago

STAT+: Eli Lilly says Verve’s gene editor lowers cholesterol levels in early study

Eli Lilly's Gene-Editing Therapy Reduces Cholesterol by 62% in Early Clinical Trial

STAT News

STAT+: Eli Lilly says Verve’s gene editor lowers cholesterol levels in early study

Opinion: How the perimenopause movement is hurting women

STAT+: Congress slashed Medicaid funding to providers. The Trump administration wants to cut even further

EU and US advisers split over AstraZeneca breast cancer drug

STAT+: Pharmalittle: We’re reading about a Parkinson’s drug setback, a Merck lung cancer therapy, and more

A CDC page on mpox caught in political crosshairs

STAT+: Longevity startup Retro Biosciences says latest fundraising values it at $1.8 billion

A federal office of men’s health has never been closer, yet it’s likely still years away

Opinion: The seed oil panic is hurting my cardiac patients

Opinion: Check-in and intake at the doctor’s office are perfect for AI

STAT+: Genentech is soliciting research that can be used to blunt pharma reforms in Washington

Mass General Brigham says it is saving more lives. Some doctors aren’t so sure.

STAT+: Closely watched experimental Parkinson’s drug fails key clinical trial

STAT+: Three burning questions senators had for the NIH director

STAT+: Merck-Kelun lung cancer drug cut risk of tumor progression by 65%, ASCO abstract shows

Guarding biotech from China and big bets in longevity

RFK Jr.’s screen time warning

STAT+: Immunovant shares surge on arthritis trial data

Acting head of NIH’s infectious disease institute reported to have stepped down

STAT+: Elevance executive ordered to testify in Medicare Advantage fraud case

Live: Senate committee questions NIH director on 2027 budget

STAT+: Pharmalittle: We’re reading about a Lilly obesity drug trial, statistics for an Alzheimer’s drug, and more

How Florida hospitals won big in Medicaid funds (just in time)

STAT+: Lilly’s ‘triple-G’ drug leads to bariatric-surgery levels of weight loss in trial

Opinion: Living with bullet fragments in the body can have long-term medical consequences

Are ‘AI co-scientist’ tools actually useful for scientists?

Opinion: STAT+: Dark times ahead at the FDA

STAT+: After warning letter, Whoop and FDA in discussions about controversial blood pressure feature

Congressional Democrats try to force a vote to end Medicare AI prior authorization pilot

STAT+: Pioneering trial for treating genetic disease before birth nears reality

Surgeon General’s office issues warning on screen time for children

STAT+: Florida hospitals win $8 billion in extra Medicaid funds

STAT+: Scientists track cellular disruptions that lead to type 1 diabetes

Opinion: I saw Ebola as both doctor and patient. I wish people cared more about the Africans I worked alongside

STAT+: Biotech execs, academic expert lament impact of FDA turnover on rare disease drug development

STAT+: Kennedy fires two leaders on preventive services task force

STAT+: Drugmakers guard IP more tightly amid China competition

STAT+: Kennedy names interim surgeon general amid vacancies atop health department

STAT+: Pharmalittle: We’re reading about biotech investors’ mood, a former FDA head’s confidence, and more

There’s a leadership vacuum at NIH, too